Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-Reactive B and T Cells

被引:84
作者
Zompi, Simona [1 ]
Santich, Brian H. [1 ]
Beatty, P. Robert [1 ,2 ]
Harris, Eva [1 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
IMMUNOGLOBULIN-G AVIDITY; ANTIBODY-MEDIATED NEUTRALIZATION; ORIGINAL ANTIGENIC SIN; LIVED PLASMA-CELLS; HEMORRHAGIC-FEVER; IMMUNE-RESPONSE; AFFINITY MATURATION; HUMORAL IMMUNITY; VIRAL-INFECTION; SHOCK SYNDROME;
D O I
10.4049/jimmunol.1102124
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The four dengue virus (DENV) serotypes cause dengue fever and dengue hemorrhagic fever/dengue shock syndrome. Although severe disease has been associated with heterotypic secondary DENV infection, most secondary DENV infections are asymptomatic or result in classic DF. The role of cross-reactive immunity in mediating cross-protection against secondary heterotypic DENV infection is not well understood. DENV infection of IFN-alpha/beta and IFN-gamma receptor-deficient (AG129) mice reproduces key features of human disease. We previously demonstrated a role in cross-protection for pre-existing cross-reactive Abs, maintained by long-lived plasma cells. In this study, we use a sequential infection model, infecting AG129 mice with DENV-1, followed by DENV-2 6-8 wk later. We find that increased DENV-specific avidity during acute secondary heterotypic infection is mediated by cross-reactive memory B cells, as evidenced by increased numbers of DENV-1-specific cells by ELISPOT and higher avidity against DENV-1 of supernatants from polyclonally stimulated splenocytes isolated from mice experiencing secondary DENV-2 infection. However, increased DENV-specific avidity is not associated with increased DENV-specific neutralization, which appears to be mediated by naive B cells. Adoptive transfer of DENV-1-immune B and T cells into naive mice prior to secondary DENV-2 infection delayed mortality. Mice depleted of T cells developed signs of disease, but recovered after secondary DENV infection. Overall, we found that protective cross-reactive Abs are secreted by both long-lived plasma cells and memory B cells and that both cross-reactive B cells and T cells provide protection against a secondary heterotypic DENV infection. Understanding the protective immunity that develops naturally against DENV infection may help design future vaccines. The Journal of Immunology, 2012, 188: 404-416.
引用
收藏
页码:404 / 416
页数:13
相关论文
共 61 条
[1]   Maintenance of the plasma cell pool is independent of memory B cells [J].
Ahuja, Anupama ;
Anderson, Shannon M. ;
Khalil, Ashraf ;
Shlomchik, Mark J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (12) :4802-4807
[2]   Mechanisms that determine plasma cell lifespan and the duration of humoral immunity [J].
Amanna, Ian J. ;
Slifka, Mark K. .
IMMUNOLOGICAL REVIEWS, 2010, 236 :125-138
[3]   Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification [J].
Balsitis, Scott J. ;
Williams, Katherine L. ;
Lachica, Ruben ;
Flores, Diana ;
Kyle, Jennifer L. ;
Mehlhop, Erin ;
Johnson, Syd ;
Diamond, Michael S. ;
Beatty, P. Robert ;
Harris, Eva .
PLOS PATHOGENS, 2010, 6 (02)
[4]   Tropism of Dengue Virus in Mice and Humans Defined by Viral Nonstructural Protein 3-Specific Immunostaining [J].
Balsitis, Scott J. ;
Coloma, Josefina ;
Castro, Glenda ;
Alava, Aracely ;
Flores, Diana ;
McKerrow, James H. ;
Beatty, P. Robert ;
Harris, Eva .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 80 (03) :416-424
[5]   Cross-reactive memory CD8+ T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner [J].
Beaumier, Coreen M. ;
Mathew, Anuja ;
Bashyam, Hema S. ;
Rothman, Alan L. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (04) :608-617
[6]  
Benner R., 1981, INDUCTION ANTIBODY F
[7]   Antibodies, viruses and vaccines [J].
Burton, DR .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) :706-713
[8]   Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis [J].
Cambridge, G ;
Leandro, MJ ;
Edwards, JCW ;
Ehrenstein, MR ;
Salden, M ;
Bodman-Smith, M ;
Webster, ADB .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2146-2154
[9]   Progressively impaired proteasomal capacity during terminal plasma cell differentiation [J].
Cenci, S ;
Mezghrani, A ;
Cascio, P ;
Bianchi, G ;
Cerruti, F ;
Fra, A ;
Lelouard, H ;
Masciarelli, S ;
Mattioli, L ;
Oliva, L ;
Orsi, A ;
Pasqualetto, E ;
Pierre, P ;
Ruffato, E ;
Tagliavacca, L ;
Sitia, R .
EMBO JOURNAL, 2006, 25 (05) :1104-1113
[10]   Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system [J].
Crotty, S ;
Aubert, RD ;
Glidewell, J ;
Ahmed, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 286 (1-2) :111-122